Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells

Journal of Cellular Physiology
Thorsten HoevelManfred Kubbies

Abstract

Claudins and occludin constitute the major transmembrane proteins of tight junctions (TJs). We have previously identified the human homologue of the murine Cldn1, CLDN1 (SEMP1) that is expressed in normal, mammary gland-derived epithelial cells but is absent in most human breast cancer cell lines. To investigate the potential functions of CLDN1 protein in tumor and normal epithelial cells, we developed an I-NGFR retroviral vector and monoclonal anti-CLDN1 antibody. In subconfluent and confluent breast cancer cells, MDA-MB-435 and MDA-MB-361, endogenous CLDN1 expression was not detected by an anti-CLDN1 monoclonal antibody by Western blot analysis or quantitative RT-PCR. When CLDN1-negative breast cancer cell lines were transduced with a CLDN1 retrovirus the cells express CLDN1 mRNA constitutively as shown by quantitative RT-PCR. Immunofluorescence analyses of the CLDN1 retroviral transduced breast tumor cells using monoclonal antibodies against CLDN1 reveals a subcellular distribution at cell-cell contact sites similar to the CLDN1 homing pattern in T47-D cells, which express endogenous CLDN1. This cell-cell contact co-localization of CLDN1 was evident in CLDN1-transduced breast tumor cells which fail to express occludin protei...Continue Reading

References

Jan 1, 1994·Breast Cancer Research and Treatment·C L SommersE P Gelmann
Dec 1, 1993·The Journal of Cell Biology·M FuruseS Tsukita
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E WillottJ M Anderson
Apr 29, 1998·Annual Review of Physiology·L L Mitic, J M Anderson
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·K MoritaS Tsukita
Jun 17, 1999·Trends in Cell Biology·S Tsukita, M Furuse
Feb 11, 2000·European Journal of Cell Biology·T InaiY Shibata
Jun 2, 2000·Gastroenterology·T KinugasaH C Reinecker
Apr 3, 2001·Nature Reviews. Molecular Cell Biology·S TsukitaM Itoh

❮ Previous
Next ❯

Citations

Mar 8, 2005·Cancer Immunology, Immunotherapy : CII·Sonja OffnerBirgit Kohleisen
Oct 7, 2011·Pflügers Archiv : European journal of physiology·Alexander G MarkovSalah Amasheh
Dec 24, 2011·Pathology Oncology Research : POR·Anna-Mária TőkésJanina Kulka
Apr 12, 2005·Advanced Drug Delivery Reviews·Karen SwisshelmManfred Kubbies
Dec 12, 2002·Progress in Biophysics and Molecular Biology·L González-MariscalB E Jaramillo
Apr 3, 2003·Journal of Dermatological Science·Kazumasa Morita, Yoshiki Miyachi
Feb 27, 2004·Journal of Mammary Gland Biology and Neoplasia·Masahiko Itoh, Mina J Bissell
Apr 21, 2010·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Carla M K MorrowRex A Hess
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Archana ThakurD Joshua Liao
Nov 12, 2009·Breast Cancer Research : BCR·Vaibhav P PaiNelson D Horseman
Mar 4, 2005·Breast Cancer Research : BCR·Anna-Mária TokésZsuzsa Schaff
May 22, 2010·Journal of Biomedicine & Biotechnology·Yvonne MyalAnne A Blanchard
Dec 4, 2015·Journal of Clinical Medicine·Bowen ZhouYvonne Myal
May 16, 2007·Progress in Histochemistry and Cytochemistry·Lorenza González-MariscalErika Garay
Nov 19, 2010·Histopathology·Silvia Vanessa LourençoFernando Augusto Soares
Jul 22, 2014·International Journal of Cancer. Journal International Du Cancer·Sivan IzraelyIsaac P Witz
Dec 9, 2008·Biochimica Et Biophysica Acta·Tracey A Martin, Wen G Jiang
Dec 2, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tracey A MartinWen G Jiang
Aug 16, 2005·Archives of Medical Research·Guelaguetza Vázquez-OrtízMauricio Salcedo
Mar 26, 2014·Tissue Barriers·Floor TwissJohan de Rooij
Sep 23, 2014·Seminars in Cell & Developmental Biology·Tracey A Martin
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Thorsten HoevelManfred Kubbies
Sep 2, 2017·Proteomics·Marta MendesJ Ignacio Casal
Apr 29, 2016·Oncology Reports·Huishan ZhaoWen G Jiang
May 27, 2014·Oncology Reports·Tracey A MartinWen G Jiang
Sep 27, 2020·Molecular Biology Reports·Marine GeoffroyIsabelle Grillier-Vuissoz
Feb 24, 2010·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Fauzia MohamedChristian Genin
May 3, 2019·Pathology Oncology Research : POR·Sami ShoushaTaneisha McFarlane
Aug 31, 2020·Pathology, Research and Practice·Claudia Fabiana Joca de ArrudaSilvia Vanessa Lourenço

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.